ID   CALX_MOUSE              Reviewed;         591 AA.
AC   P35564;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1994, sequence version 1.
DT   03-AUG-2022, entry version 202.
DE   RecName: Full=Calnexin;
DE   Flags: Precursor;
GN   Name=Canx;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8136357; DOI=10.1021/bi00177a013;
RA   Tjoelker L.W., Seyfried C.E., Eddy R.L. Jr., Shows T.B. Jr., Calderon J.,
RA   Schreiber R.B., Gray P.W.;
RT   "Human, mouse, and rat calnexin cDNA cloning: identification of potential
RT   calcium binding motifs and gene localization to human chromosome 5.";
RL   Biochemistry 33:3229-3236(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=FVB/N; TISSUE=Mammary gland;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-155.
RC   STRAIN=C57BL/6J; TISSUE=Eye;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 21-591.
RC   STRAIN=BALB/cJ;
RX   PubMed=8148318; DOI=10.1093/intimm/6.1.101;
RA   Schreiber K.L., Bell M.P., Huntoon C.J., Rajagopalan S., Brenner M.B.,
RA   McKean D.J.;
RT   "Class II histocompatibility molecules associate with calnexin during
RT   assembly in the endoplasmic reticulum.";
RL   Int. Immunol. 6:101-111(1994).
RN   [5]
RP   FUNCTION IN THYMOCYTE MATURATION, AND SUBCELLULAR LOCATION.
RX   PubMed=7628443; DOI=10.1002/j.1460-2075.1995.tb07348.x;
RA   Wiest D.L., Burgess W.H., McKean D., Kearse K.P., Singer A.;
RT   "The molecular chaperone calnexin is expressed on the surface of immature
RT   thymocytes in association with clonotype-independent CD3 complexes.";
RL   EMBO J. 14:3425-3433(1995).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-553, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Teratocarcinoma;
RX   PubMed=17622165; DOI=10.1021/pr070122r;
RA   Smith J.C., Duchesne M.A., Tozzi P., Ethier M., Figeys D.;
RT   "A differential phosphoproteomic analysis of retinoic acid-treated P19
RT   cells.";
RL   J. Proteome Res. 6:3174-3186(2007).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain cortex;
RX   PubMed=17114649; DOI=10.1074/mcp.m600046-mcp200;
RA   Munton R.P., Tweedie-Cullen R., Livingstone-Zatchej M., Weinandy F.,
RA   Waidelich M., Longo D., Gehrig P., Potthast F., Rutishauser D., Gerrits B.,
RA   Panse C., Schlapbach R., Mansuy I.M.;
RT   "Qualitative and quantitative analyses of protein phosphorylation in naive
RT   and stimulated mouse synaptosomal preparations.";
RL   Mol. Cell. Proteomics 6:283-293(2007).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-553; SER-563 AND SER-582, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=17208939; DOI=10.1074/mcp.m600218-mcp200;
RA   Lee J., Xu Y., Chen Y., Sprung R., Kim S.C., Xie S., Zhao Y.;
RT   "Mitochondrial phosphoproteome revealed by an improved IMAC method and
RT   MS/MS/MS.";
RL   Mol. Cell. Proteomics 6:669-676(2007).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=18630941; DOI=10.1021/pr800223m;
RA   Zhou H., Ye M., Dong J., Han G., Jiang X., Wu R., Zou H.;
RT   "Specific phosphopeptide enrichment with immobilized titanium ion affinity
RT   chromatography adsorbent for phosphoproteome analysis.";
RL   J. Proteome Res. 7:3957-3967(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-553; SER-563 AND SER-582, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19144319; DOI=10.1016/j.immuni.2008.11.006;
RA   Trost M., English L., Lemieux S., Courcelles M., Desjardins M.,
RA   Thibault P.;
RT   "The phagosomal proteome in interferon-gamma-activated macrophages.";
RL   Immunity 30:143-154(2009).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-582, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic fibroblast;
RX   PubMed=19131326; DOI=10.1074/mcp.m800451-mcp200;
RA   Sweet S.M., Bailey C.M., Cunningham D.L., Heath J.K., Cooper H.J.;
RT   "Large scale localization of protein phosphorylation by use of electron
RT   capture dissociation mass spectrometry.";
RL   Mol. Cell. Proteomics 8:904-912(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-553 AND SER-563, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, Brown adipose tissue, Heart, Kidney, Liver, Lung,
RC   Pancreas, Spleen, and Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [13]
RP   FUNCTION, AND INTERACTION WITH SGIP1.
RX   PubMed=21747946; DOI=10.1371/journal.pone.0021678;
RA   Li H.D., Liu W.X., Michalak M.;
RT   "Enhanced clathrin-dependent endocytosis in the absence of calnexin.";
RL   PLoS ONE 6:E21678-E21678(2011).
RN   [14]
RP   INTERACTION WITH TMEM35A/NACHO.
RX   PubMed=32783947; DOI=10.1016/j.celrep.2020.108025;
RA   Kweon H.J., Gu S., Witham E., Dhara M., Yu H., Mandon E.D., Jawhari A.,
RA   Bredt D.S.;
RT   "NACHO Engages N-Glycosylation ER Chaperone Pathways for alpha7 Nicotinic
RT   Receptor Assembly.";
RL   Cell Rep. 32:108025-108025(2020).
CC   -!- FUNCTION: Calcium-binding protein that interacts with newly synthesized
CC       monoglucosylated glycoproteins in the endoplasmic reticulum. It may act
CC       in assisting protein assembly and/or in the retention within the ER of
CC       unassembled protein subunits. It seems to play a major role in the
CC       quality control apparatus of the ER by the retention of incorrectly
CC       folded proteins. Associated with partial T-cell antigen receptor
CC       complexes that escape the ER of immature thymocytes, it may function as
CC       a signaling complex regulating thymocyte maturation. Additionally it
CC       may play a role in receptor-mediated endocytosis at the synapse.
CC       {ECO:0000269|PubMed:21747946, ECO:0000269|PubMed:7628443}.
CC   -!- SUBUNIT: Interacts with MAPK3/ERK1 (By similarity). Interacts with
CC       KCNH2 (By similarity). Associates with ribosomes (By similarity). The
CC       palmitoylated form interacts with the ribosome-translocon complex
CC       component SSR1, promoting efficient folding of glycoproteins (By
CC       similarity). Interacts with SERPINA2P/SERPINA2 and with the S and Z
CC       variants of SERPINA1 (By similarity). Interacts with SGIP1; involved in
CC       negative regulation of endocytosis (PubMed:21747946). Interacts with
CC       PPIB (By similarity). Interacts with SMIM22 (By similarity). Interacts
CC       with TMX2 (By similarity). Interacts with TMEM35A/NACHO
CC       (PubMed:32783947). Interacts with CHRNA7 (By similarity).
CC       {ECO:0000250|UniProtKB:P27824, ECO:0000250|UniProtKB:P35565,
CC       ECO:0000269|PubMed:21747946, ECO:0000269|PubMed:32783947}.
CC   -!- INTERACTION:
CC       P35564; Q8VD37: Sgip1; NbExp=3; IntAct=EBI-738422, EBI-776269;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:7628443}; Single-pass type I membrane protein
CC       {ECO:0000255}. Endoplasmic reticulum {ECO:0000250|UniProtKB:P27824}.
CC       Melanosome {ECO:0000250|UniProtKB:P27824}. Note=The palmitoylated form
CC       preferentially localizes to the perinuclear rough ER (By similarity).
CC       When bound to CD3 epsilon chains, calnexin's ER retention signal can be
CC       masked, permitting it to escape ER retention.
CC       {ECO:0000250|UniProtKB:P27824}.
CC   -!- PTM: Phosphorylated at Ser-563 by MAPK3/ERK1. phosphorylation by
CC       MAPK3/ERK1 increases its association with ribosomes (By similarity).
CC       {ECO:0000250}.
CC   -!- PTM: Palmitoylation by DHHC6 leads to the preferential localization to
CC       the perinuclear rough ER. It mediates the association of calnexin with
CC       the ribosome-translocon complex (RTC) which is required for efficient
CC       folding of glycosylated proteins (By similarity). {ECO:0000250}.
CC   -!- PTM: Ubiquitinated, leading to proteasomal degradation. Probably
CC       ubiquitinated by ZNRF4. {ECO:0000250|UniProtKB:P27824}.
CC   -!- SIMILARITY: Belongs to the calreticulin family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L18888; AAA21014.1; -; mRNA.
DR   EMBL; BC012408; AAH12408.1; -; mRNA.
DR   EMBL; BC040244; AAH40244.1; -; mRNA.
DR   EMBL; AK084175; BAC39133.1; -; mRNA.
DR   EMBL; L23865; AAA62450.1; -; mRNA.
DR   CCDS; CCDS24633.1; -.
DR   PIR; B54354; B54354.
DR   RefSeq; NP_001103969.1; NM_001110499.1.
DR   RefSeq; NP_001103970.1; NM_001110500.1.
DR   RefSeq; NP_031623.1; NM_007597.3.
DR   AlphaFoldDB; P35564; -.
DR   SMR; P35564; -.
DR   BioGRID; 198467; 46.
DR   CORUM; P35564; -.
DR   IntAct; P35564; 15.
DR   MINT; P35564; -.
DR   STRING; 10090.ENSMUSP00000020637; -.
DR   iPTMnet; P35564; -.
DR   PhosphoSitePlus; P35564; -.
DR   SwissPalm; P35564; -.
DR   EPD; P35564; -.
DR   jPOST; P35564; -.
DR   PaxDb; P35564; -.
DR   PeptideAtlas; P35564; -.
DR   PRIDE; P35564; -.
DR   ProteomicsDB; 265514; -.
DR   Antibodypedia; 2421; 1151 antibodies from 46 providers.
DR   DNASU; 12330; -.
DR   Ensembl; ENSMUST00000020637; ENSMUSP00000020637; ENSMUSG00000020368.
DR   Ensembl; ENSMUST00000179865; ENSMUSP00000137440; ENSMUSG00000020368.
DR   GeneID; 12330; -.
DR   KEGG; mmu:12330; -.
DR   UCSC; uc007isf.2; mouse.
DR   CTD; 821; -.
DR   MGI; MGI:88261; Canx.
DR   VEuPathDB; HostDB:ENSMUSG00000020368; -.
DR   eggNOG; KOG0675; Eukaryota.
DR   GeneTree; ENSGT00950000182915; -.
DR   HOGENOM; CLU_018224_2_0_1; -.
DR   InParanoid; P35564; -.
DR   OMA; ANPKCEA; -.
DR   OrthoDB; 775337at2759; -.
DR   PhylomeDB; P35564; -.
DR   TreeFam; TF300618; -.
DR   Reactome; R-MMU-2132295; MHC class II antigen presentation.
DR   Reactome; R-MMU-901042; Calnexin/calreticulin cycle.
DR   Reactome; R-MMU-983170; Antigen Presentation: Folding, assembly and peptide loading of class I MHC.
DR   BioGRID-ORCS; 12330; 2 hits in 74 CRISPR screens.
DR   ChiTaRS; Canx; mouse.
DR   PRO; PR:P35564; -.
DR   Proteomes; UP000000589; Chromosome 11.
DR   RNAct; P35564; protein.
DR   Bgee; ENSMUSG00000020368; Expressed in ureteric bud tip and 254 other tissues.
DR   ExpressionAtlas; P35564; baseline and differential.
DR   Genevisible; P35564; MM.
DR   GO; GO:0030424; C:axon; ISO:MGI.
DR   GO; GO:0005737; C:cytoplasm; ISO:MGI.
DR   GO; GO:0032839; C:dendrite cytoplasm; ISO:MGI.
DR   GO; GO:0043197; C:dendritic spine; ISO:MGI.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; ISS:AgBase.
DR   GO; GO:0044322; C:endoplasmic reticulum quality control compartment; IDA:UniProtKB.
DR   GO; GO:0098978; C:glutamatergic synapse; ISO:MGI.
DR   GO; GO:0071556; C:integral component of lumenal side of endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IDA:MGI.
DR   GO; GO:0099055; C:integral component of postsynaptic membrane; ISO:MGI.
DR   GO; GO:0099059; C:integral component of presynaptic active zone membrane; ISO:MGI.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; IDA:MGI.
DR   GO; GO:0044233; C:mitochondria-associated endoplasmic reticulum membrane; ISO:MGI.
DR   GO; GO:0043209; C:myelin sheath; HDA:UniProtKB.
DR   GO; GO:0043025; C:neuronal cell body; ISO:MGI.
DR   GO; GO:0032991; C:protein-containing complex; ISO:MGI.
DR   GO; GO:0005840; C:ribosome; ISO:MGI.
DR   GO; GO:0005791; C:rough endoplasmic reticulum; ISO:MGI.
DR   GO; GO:0005790; C:smooth endoplasmic reticulum; ISO:MGI.
DR   GO; GO:0034185; F:apolipoprotein binding; ISO:MGI.
DR   GO; GO:0005509; F:calcium ion binding; IBA:GO_Central.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:UniProtKB-KW.
DR   GO; GO:0035255; F:ionotropic glutamate receptor binding; ISO:MGI.
DR   GO; GO:0051082; F:unfolded protein binding; IEA:InterPro.
DR   GO; GO:0007568; P:aging; IEA:Ensembl.
DR   GO; GO:0072583; P:clathrin-dependent endocytosis; IMP:UniProtKB.
DR   GO; GO:0006457; P:protein folding; IBA:GO_Central.
DR   GO; GO:0048488; P:synaptic vesicle endocytosis; IDA:SynGO.
DR   GO; GO:0030433; P:ubiquitin-dependent ERAD pathway; IBA:GO_Central.
DR   Gene3D; 2.10.250.10; -; 1.
DR   InterPro; IPR001580; Calret/calnex.
DR   InterPro; IPR018124; Calret/calnex_CS.
DR   InterPro; IPR009033; Calreticulin/calnexin_P_dom_sf.
DR   InterPro; IPR013320; ConA-like_dom_sf.
DR   PANTHER; PTHR11073; PTHR11073; 1.
DR   Pfam; PF00262; Calreticulin; 1.
DR   PRINTS; PR00626; CALRETICULIN.
DR   SUPFAM; SSF49899; SSF49899; 2.
DR   SUPFAM; SSF63887; SSF63887; 1.
DR   PROSITE; PS00803; CALRETICULIN_1; 1.
DR   PROSITE; PS00804; CALRETICULIN_2; 1.
DR   PROSITE; PS00805; CALRETICULIN_REPEAT; 3.
PE   1: Evidence at protein level;
KW   Acetylation; Calcium; Chaperone; Disulfide bond; Endoplasmic reticulum;
KW   Lectin; Lipoprotein; Membrane; Metal-binding; Palmitate; Phosphoprotein;
KW   Reference proteome; Repeat; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL          1..20
FT                   /evidence="ECO:0000255"
FT   CHAIN           21..591
FT                   /note="Calnexin"
FT                   /id="PRO_0000004199"
FT   TOPO_DOM        21..482
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        483..503
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        504..591
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   REPEAT          279..291
FT                   /note="1-1"
FT   REPEAT          296..308
FT                   /note="1-2"
FT   REPEAT          315..327
FT                   /note="1-3"
FT   REPEAT          334..346
FT                   /note="1-4"
FT   REPEAT          349..359
FT                   /note="2-1"
FT   REPEAT          368..378
FT                   /note="2-2"
FT   REPEAT          382..392
FT                   /note="2-3"
FT   REPEAT          396..406
FT                   /note="2-4"
FT   REGION          261..347
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          277..410
FT                   /note="P domain (Extended arm)"
FT                   /evidence="ECO:0000250"
FT   REGION          279..346
FT                   /note="4 X approximate repeats"
FT   REGION          327..360
FT                   /note="Interaction with PPIB"
FT                   /evidence="ECO:0000250"
FT   REGION          349..406
FT                   /note="4 X approximate repeats"
FT   REGION          504..591
FT                   /note="Sufficient to mediate interaction with SGIP1"
FT                   /evidence="ECO:0000269|PubMed:21747946"
FT   REGION          514..591
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        275..327
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        328..347
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        519..584
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         75
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250"
FT   BINDING         118
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250"
FT   BINDING         165
FT                   /ligand="an alpha-D-glucoside"
FT                   /ligand_id="ChEBI:CHEBI:22390"
FT                   /evidence="ECO:0000250|UniProtKB:P14211"
FT   BINDING         167
FT                   /ligand="an alpha-D-glucoside"
FT                   /ligand_id="ChEBI:CHEBI:22390"
FT                   /evidence="ECO:0000250|UniProtKB:P14211"
FT   BINDING         186
FT                   /ligand="an alpha-D-glucoside"
FT                   /ligand_id="ChEBI:CHEBI:22390"
FT                   /evidence="ECO:0000250|UniProtKB:P14211"
FT   BINDING         193
FT                   /ligand="an alpha-D-glucoside"
FT                   /ligand_id="ChEBI:CHEBI:22390"
FT                   /evidence="ECO:0000250|UniProtKB:P14211"
FT   BINDING         426
FT                   /ligand="an alpha-D-glucoside"
FT                   /ligand_id="ChEBI:CHEBI:22390"
FT                   /evidence="ECO:0000250|UniProtKB:P14211"
FT   BINDING         437
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         138
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P27824"
FT   MOD_RES         553
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17208939,
FT                   ECO:0007744|PubMed:17622165, ECO:0007744|PubMed:19144319,
FT                   ECO:0007744|PubMed:21183079"
FT   MOD_RES         561
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P27824"
FT   MOD_RES         563
FT                   /note="Phosphoserine; by MAPK3"
FT                   /evidence="ECO:0007744|PubMed:17208939,
FT                   ECO:0007744|PubMed:19144319, ECO:0007744|PubMed:21183079"
FT   MOD_RES         582
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17208939,
FT                   ECO:0007744|PubMed:19131326, ECO:0007744|PubMed:19144319"
FT   LIPID           503
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000250"
FT   LIPID           504
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000250"
FT   DISULFID        161..195
FT                   /evidence="ECO:0000250"
FT   DISULFID        361..367
FT                   /evidence="ECO:0000250"
FT   CONFLICT        416
FT                   /note="K -> R (in Ref. 4; AAA62450)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        468
FT                   /note="P -> L (in Ref. 4; AAA62450)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        472
FT                   /note="L -> G (in Ref. 4; AAA62450)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        538
FT                   /note="R -> G (in Ref. 4; AAA62450)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        560
FT                   /note="V -> G (in Ref. 4; AAA62450)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   591 AA;  67278 MW;  0D9F8FE03434BADC CRC64;
     MEGKWLLCLL LVLGTAAVEA HDGHDDDAID IEDDLDDVIE EVEDSKSKSD ASTPPSPKVT
     YKAPVPTGEV YFADSFDRGS LSGWILSKAK KDDTDDEIAK YDGKWEVDEM KETKLPGDKG
     LVLMSRAKHH AISAKLNKPF LFDTKPLIVQ YEVNFQNGIE CGGAYVKLLS KTAELSLDQF
     HDKTPYTIMF GPDKCGEDYK LHFIFRHKNP KTGVYEEKHA KRPDADLKTY FTDKKTHLYT
     LILNPDNSFE ILVDQSVVNS GNLLNDMTPP VNPSREIEDP EDRKPEDWDE RPKIADPDAV
     KPDDWDEDAP SKIPDEEATK PEGWLDDEPE YIPDPDAEKP EDWDEDMDGE WEAPQIANPK
     CESAPGCGVW QRPMIDNPNY KGKWKPPMID NPNYQGIWKP RKIPNPDFFE DLEPFKMTPF
     SAIGLELWSM TSDIFFDNFI ISGDRRVVDD WANDGWGLKK AADGAAEPGV VLQMLEAAEE
     RPWLWVVYIL TVALPVFLVI LFCCSGKKQS NAMEYKKTDA PQPDVKDEEG KEEEKNKRDE
     EEEEEKLEEK QKSDAEEDGV TGSQDEEDSK PKAEEDEILN RSPRNRKPRR E
//
